According to @EricBalchunas, generic listing standards now render the 19b-4 filings and their statutory clock meaningless for this product class, leaving only the S-1 registrations awaiting a formal green light from the SEC Division of Corporation Finance, which he says shifts the timing focus to final S-1 effectiveness for potential listing triggers (source: Eric Balchunas on X, Sep 29, 2025, link: https://twitter.com/EricBalchunas/status/1972779124679975004). According to @EricBalchunas, issuers have submitted amendment number 4 for the Solana spot ETF S-1, which he interprets as the process entering its final stage with approval odds now at 100 percent (source: Eric Balchunas on X, Sep 29, 2025, link: https://twitter.com/EricBalchunas/status/1972779124679975004). According to @EricBalchunas, the listing could come any day and he advises market participants to be ready, implying near-term headline sensitivity for SOL once Corp Finance issues the formal green light on the S-1s (source: Eric Balchunas on X, Sep 29, 2025, link: https://twitter.com/EricBalchunas/status/1972779124679975004).

According to WallStreetBulls, the approval odds for an XRP Spot ETF have surged to 79%, indicating growing market confidence and potential for significant price movement in the near term (source: WallStreetBulls, May 4, 2025). This uptick in approval probability is likely to drive increased trading volumes and volatility in XRP as investors position themselves ahead of possible SEC decisions. Traders should closely monitor regulatory news and price action, as ETF-related developments have historically resulted in sharp market reactions.